Kreos Capital

A leading venture and growth debt provider for technology and healthcare companies in Europe and Israel.

Venture Capital London, United Kingdom Est. 1998
LinkedIn
Last updated 2026-07-20
Portfolio
6
in our dataset
Rounds participated
6
Rounds led
4
Rounds' value
$111.0M
total disclosed, rounds participated
Stages
F Round, G Round, E Round, D Round

About

Kreos Capital is a venture and growth debt provider that offers flexible debt financing solutions to high-growth technology and healthcare companies across Europe and Israel. The firm supports companies through various growth stages, from entry-level to late-stage and pre-IPO/exit funding. Kreos Capital was acquired by BlackRock in 2023, and its team integrated into BlackRock's European Private Debt platform.

Portfolio · 6

Fairtility
Fairtility powers in vitro fertilization (IVF) through transparent artificial intelligence to improve outcomes.
Led ★ 1 round Latest: 2024-02
Variantyx
A technology-driven molecular diagnostics company providing advanced genomic testing for genetic disorders, reproductive health, and precision oncology markets.
Led ★ 1 round $20.0M committed Latest: 2022-10
Zerto
One continuous software experience for ransomware resilience, disaster recovery, and data mobility for on-premises and cloud.
Led ★ 1 round $33.0M committed Latest: 2020-06
BioCatch
Provider of behavioral biometrics cybersecurity solutions that analyze online user behavior to prevent fraud, detect impersonation, and provide digital identity verification and security for financial institutions and other organizations.
1 round $30.0M committed Latest: 2018-03
Zooz
An open payment platform designed to help businesses enhance their payment value and increase conversion rates.
1 round $24.0M committed Latest: 2016-05
Riskified
Riskified is a publicly traded company that provides software as a service (SaaS) fraud and chargeback prevention technology.
Led ★ 1 round $4.0M committed Latest: 2014-02

Investment activity

6 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences8
Industrial Technologies4
Business Software3
Media & Entertainment Technologies2
Cyber Security2
Fintech & Insurtech2
Automotive & Mobility Technologies1
Undisclosed1

Q&A

What was Kreos Capital's most recent exit?
Kreos Capital's most recent exit was BioCatch, which was acquired by Permira in May 2024 for $750M.
Which sectors does Kreos Capital primarily invest in?
Kreos Capital shows a strong concentration in Health Tech & Life Sciences with 8 portfolio companies, followed by Industrial Technologies with 4, and Business Software with 3.
Can you name some of Kreos Capital's notable portfolio companies?
Kreos Capital's portfolio includes companies like AKEYLESS, which is a unified secrets and non-human identity platform, and BioCatch, an AI-driven behavioral biometrics company for cybersecurity.
What is Kreos Capital's investment stage focus?
Kreos Capital primarily invests in later stages, with listed investment stages including F Round, G Round, E Round, and D Round. Their funding rounds data also shows a significant number of C Round and Debt Financing investments.
How many exits has Kreos Capital had in the last two years?
Kreos Capital has had one exit in the last two years, with BioCatch being acquired in May 2024.
What is the total capital raised by some of Kreos Capital's portfolio companies?
Notable portfolio companies include Bluevine, which has raised $286M, and Gett, which has raised $708M.
What is the geographic focus of Kreos Capital?
Kreos Capital is headquartered in the United Kingdom and has a global investment scope, with portfolio companies located in 16 countries.
Who are some of the key personnel at Kreos Capital?
Key personnel at Kreos Capital include Uri Galai, a Managing Director, and Parag Gandesha, a Managing Director & COO.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)